Company Profile

Home
Markets
Company Profile

Mazagon Dock
2,750.00 2,929.98(%)
Tejas Networks
902.70 1,495.10(%)
Hind.Aeronautics
4,328.95 5,675.00(%)
Kalyan Jewellers
497.15 337.00(%)
Adani Power
538.00 896.75(%)
TCS
3,396.10 3,396.10(%)
Reliance Industr
1,234.55 1,156.00(%)
Bharat Electron
288.30 340.35(%)
Persistent Sys
4,764.75 3,232.60(%)
Vodafone Idea
8.06 6.60(%)
Tata Motors
652.80 606.20(%)
Infosys
1,485.10 1,359.10(%)
Angel One
2,475.00 3,502.60(%)
Jio Financial
231.75 394.70(%)
HDFC Bank
1,776.70 1,430.15(%)
Nippon ETF Liq.
1,000.01 1,005.00(%)
Reliance Power
44.44 54.25(%)
Zomato Ltd
208.35 146.85(%)
ICICI Pru. BSE
999.99 998.75(%)
Emcure Pharma
1,025.75 911.75(%)

Overview
Key Ratios
Financials
Shareholding
Company Info
Peer Comparison

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

Indian Private
BSE Code : 5905.0
ISIN : INE646B01010

523.00 37 (7.71%)

As on 03 Apr 2025 (EOD)

Today’s Low
483.75
Today’s High
544.00

Open
485.55
Perv Close
485.55
52W Low
375.05
52W High
630.00

Key Indicators

P/E(TTM)

66.09
Mar.Cap (₹Cr.)

664.97
Div & Yield %

0.19
Book Value(₹)

173.40
Debt-Equity Ratio

7.71
AGM Date

03-Apr-2025
EPS

7.98
P/E Ratio

66.09

Financials Ratios

Debt-Equity Ratio

0.14
Mar.Cap (₹Cr.)

664.97

RONW (%)

4.74
ROCE (%)

8.14

Score Board

Equity (₹ in Cr.)

12.71
BV (₹)

173.40
Sales( ₹ in Cr.)

172.39
NP (in Cr.)

13.30
NP Var(%)

-11.0
Div%

10.0
CPS (₹)

16.00
EPS (₹)

10.50
Traded Value (₹ in Lakhs)

670.57

52 Week High

630.00
52 Week Low

375.05
Price BSE

527.0
Price NSE

523.00
Market Capital( in Cr.)

670.57
P/C Ratio

33.00
P/E Ratio

50.40
Price Vs.BV

10.50

27-Feb-2025( 04:47)

Corporate News - Medic... - Medicamen Biotech announced th...
21-Feb-2025( 07:50)

Corporate News - Medic... - Medicamen Biotech will hold a...
11-Feb-2025( 05:46)

Results - Announcements - Medic... - Net profit of Medicamen Biotec...
11-Feb-2025( 05:42)

Results - Announcements - Medic... - Net profit of Medicamen Biotec...

Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)

Particulars(INCOME)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales Turnover	172.39	137.88	115.45	110.15	117.34	122.60
Excise Duty	170.96	137.43	108.29	108.15	115.46	121.23
Net Sales	172.39	137.88	115.45	110.15	117.34	122.60
Other Income	2.30	2.46	1.72	0.75	1.91	3.66
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	174.69	140.35	117.17	110.90	119.25	126.26
EXPENDITURE :
Raw Materials	170.96	137.43	108.29	108.15	115.46	121.23
Power & Fuel Cost	170.96	137.43	108.29	108.15	115.46	121.23
Employee Cost	22.12	18.57	14.50	8.79	9.29	8.09
Other Manufacturing Expenses	3.14	2.64	2.06	0.91	0.91	0.80
Selling & Administrative Expenses	12.50	6.71	7.54	3.96	4.46	5.34
Miscellaneous Expenses	3.14	2.64	2.06	0.91	0.91	0.80
Less : Pre-operative Expenses Capitalised :
Total Expenditure	157.80	123.01	99.06	94.15	102.65	108.74
Operating Profit	17.28	14.31	15.43	10.03	11.96	8.03
Interest	4.38	2.92	1.40	1.06	0.57	0.94
Gross Profit	16.89	17.33	18.10	16.75	16.60	17.52
Depreciation	7.01	6.35	5.77	2.52	2.50	2.21
Profit Before Tax	16.89	17.33	18.10	16.75	16.60	17.52
Tax	4.22	3.70	3.98	4.15	4.60	5.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.63	-1.37	-0.78	0.12	-0.25	0.00
Reported Net Profit	13.30	15.00	14.91	12.49	12.26	12.03
Extraordinary Items	16.89	17.33	18.10	16.75	16.60	17.52
Adjusted Net Profit	13.30	15.00	14.91	12.49	12.26	12.03
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	0.00	0.00	0.00	0.00	0.00	0.00
Statutory Appropriations	1.27	1.27	1.22	1.22	0.61	1.22
P & L Balance carried down	13.30	15.00	14.91	12.49	12.26	12.03
Dividend	-	-	-	-	-	-
Preference Dividend	-	-	-	-	-	-
Equity Dividend (%)	10.00	10.00	10.00	10.00	5.00	10.00
Dividend Per Share(Rs)	1.00	1.00	1.00	1.00	0.50	1.00
Earnings Per Share-Unit Curr	10.50	12.04	12.20	10.22	10.09	10.28
Book Value	1.27	1.27	1.22	1.22	0.61	1.22
Book Value(Adj)-Unit Curr	1.27	1.27	1.22	1.22	0.61	1.22

Shareholding Pattern

Promoter Group

42.99%
Public Share Holding

57.01%

Category of Shareholder	No of Shares	% Holdings	Demat Shares	Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0
Sub Total	0	0.00	0	0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group)	5,466,095	42.99	5,466,095	1
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	0	0.00	0	0
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0
Sub Total	5,466,095	42.99	5,466,095	1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State)	7,000	0.06	7,000	1
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	6,658	0.05	6,658	2
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	0	0.00	0	0
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	110,000	0.87	110,000	1
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0
Sub total	123,658	0.97	123,658	4
2] Non Institution
Bodies Corporate	367,307	2.89	363,807	121
Clearing Members	0	0.00	0	0
Directors of their Relatives	202,813	1.60	202,813	1
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	165,497	1.30	165,497	2
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	52,762	0.42	52,562	155
Foreign Non Institution Other	1,340,000	10.54	1,340,000	1
Hindu Undivided Families	465,559	3.66	465,559	357
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	1,297,834	10.21	1,297,834	31
Individuals holding nominal share capital up to Rs. 1 lakh	2,892,943	22.75	2,828,320	9,885
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	0	0.00	0	0
Others	284,093	2.23	284,093	3
Sub Total	7,124,847	56.04	7,056,524	10,571
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0
Total Shares held by Custodians and against which Depository Receipts have been issued	0	0.00	0	0
Grand Total ( A + B + C )	12,714,600	100.00	12,646,277	10,576

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

Medicamen Biotech Ltd
BSE Code : 5905.0
ISIN : INE646B01010

Incorporation Year

1993
Registered Office

1506 Chiranjiv Tower 43
Nehru Place, New Delhi,
New Delhi-110019
Telephone

91-11-47589500
FAX

91-11-26213081
Chairman

Rahul Bishnoi
Managing Director
Company Secretary

Parul Choudhary
Auditor

Rai Qimat & Associates
Face Value

10
Listing

NSE
Registrar

Link Intime India Pvt Ltd
Narang Tower,
44 Community Centre,Naraina Ind Area
Mumbai - New Delhi-110028

Medicamen Biotech Ltd Peer Comparison

Profit & Loss

Financial Ratios

Balance Sheet

Company Name	LTP (₹)	Revenue	Sales	P/E Ratio	ROCE %
Medicamen Biotec	527.40	174.69	172.39	66.09	9.76
Abbott India	29,940.35	6,097.18	5,848.91	47.68	44.71
Astrazeneca Phar	8,092.00	1,330.33	1,295.53	208.61	33.26
P & G Health Ltd	5,295.80	1,166.89	1,151.26	37.16	39.76
Glaxosmi. Pharma	2,857.90	3,530.73	3,407.25	56.83	44.44
Cipla	1,495.15	17,645.00	16,574.34	25.63	20.10
Amrutanjan Healt	666.30	437.58	421.23	39.06	20.84
Fermenta Biotec.	305.85	315.24	307.09	28.99	4.10
Guj. Themis Bio.	282.25	174.19	169.82	58.44	44.82
Bliss GVS Pharma	126.20	638.96	605.46	28.88	11.19
Ambalal Sarabhai	40.33	11.70	3.81	17.24	1.92

Mazagon Dock

Tejas Networks

Hind.Aeronautics

Kalyan Jewellers

Adani Power

TCS

Reliance Industr

Bharat Electron

Persistent Sys

Vodafone Idea

Tata Motors

Infosys

Angel One

Jio Financial

HDFC Bank

Nippon ETF Liq.

Reliance Power

Zomato Ltd

ICICI Pru. BSE

Emcure Pharma

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

523.00 37 (7.71%)

Key Indicators

Financials Ratios

Score Board

Navigate The Market With Confidence

Financials

Shareholding Pattern

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

Medicamen Biotech Ltd Peer Comparison